Position in MRK
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$13,676,897
+$2,461,971 QoQ
Shares Held
106,435
-0.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#639
of 3,778 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUST CO OF VERMONT holds $143,988,175 across 14 Drug Manufacturers - General names. MRK ranks #3 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
212,013 | $53,844,941 | |
| 2 | ABBV |
AbbVie Inc.
|
162,450 | $40,878,917 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
106,435 | $13,676,897 | |
| 4 | LLY |
ELI LILLY & Co
|
8,529 | $10,229,939 | |
| 5 | AMGN |
Amgen Inc
|
22,744 | $8,236,057 | |
| 6 | NVS |
Novartis AG
|
46,466 | $7,282,150 | |
| 7 | PFE |
Pfizer Inc
|
158,728 | $3,822,169 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
49,346 | $2,843,316 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,676,897 | 106,435 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $11,214,926 | 106,545 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $8,986,636 | 107,073 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $8,616,327 | 108,847 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $9,887,961 | 110,160 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $11,573,303 | 116,338 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $14,404,744 | 126,847 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $16,025,785 | 129,449 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $17,057,439 | 129,272 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $12,813,229 | 117,531 | Shares | Sole | 2024-03-08 | |
| 2023-09-30 | $13,307,007 | 129,257 | Shares | Sole | 2023-11-27 | |
| 2023-06-30 | $14,731,148 | 127,664 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $13,291,621 | 124,933 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $13,422,397 | 120,977 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $10,393,391 | 120,685 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $9,970,897 | 109,366 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $8,654,961 | 105,484 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $7,911,010 | 103,223 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $7,397,809 | 98,493 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $6,648,945 | 85,495 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $6,138,448 | 79,627 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $5,287,794 | 64,643 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $5,255,630 | 63,359 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $4,850,061 | 62,719 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $7,203,657 | 93,627 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||